Page last updated: 2024-10-31

moclobemide and Adolescent Gynecomastia

moclobemide has been researched along with Adolescent Gynecomastia in 1 studies

Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.

Research Excerpts

ExcerptRelevanceReference
"After 180-d moclobemide treatment, the presence of gynecomastia was 0, 5, 5, 7/10 rats in 0, 60, 240, and 600 mg/kg groups, respectively."7.70Moclobemide-induced gynecomastia in rats. ( Liu, JH; Ma, XC; Tu, ZH; Wang, Y, 2000)
"After 180-d moclobemide treatment, the presence of gynecomastia was 0, 5, 5, 7/10 rats in 0, 60, 240, and 600 mg/kg groups, respectively."3.70Moclobemide-induced gynecomastia in rats. ( Liu, JH; Ma, XC; Tu, ZH; Wang, Y, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ma, XC1
Wang, Y1
Liu, JH1
Tu, ZH1

Other Studies

1 other study available for moclobemide and Adolescent Gynecomastia

ArticleYear
Moclobemide-induced gynecomastia in rats.
    Acta pharmacologica Sinica, 2000, Volume: 21, Issue:10

    Topics: Animals; Gynecomastia; Male; Mammary Glands, Animal; Moclobemide; Prolactin; Rats; Rats, Sprague-Daw

2000